62832 results
-
List item
Orphan designation: autologous CD4+ and CD8+ T cells transduced with lentiviral vector containing an affinity-enhanced T-cell receptor targeting the New York esophageal antigen-1 for: Treatment of soft tissue sarcoma (updated)
Date of first decision: 14/07/2016, Positive, Last updated: 07/04/2020 -
List item
Orphan designation: Humanised monoclonal antibody targeting B-cell maturation antigen conjugated with maleimidocaproyl monomethyl auristatin F for: Treatment of multiple myeloma (updated)
Date of first decision: 16/10/2017, Positive, Last updated: 07/04/2020 -
List item
Orphan designation: Mepolizumab for: Treatment of hypereosinophilic syndrome (updated)
Date of first decision: 29/07/2004, Positive, Last updated: 07/04/2020 -
List item
Orphan designation: Mepolizumab for: Treatment of Churg-Strauss syndrome (updated)
Date of first decision: 12/03/2013, Positive, Last updated: 07/04/2020 -
List item
Human medicine European public assessment report (EPAR): Trizivir (updated)
abacavir (as sulfate), lamivudine, zidovudine, HIV Infections
Date of authorisation: 27/12/2000, Revision: 33, Authorised, Last updated: 07/04/2020 -
List item
Human medicine European public assessment report (EPAR): Viagra (updated)
sildenafil, Erectile Dysfunction
Date of authorisation: 13/09/1998, Revision: 35, Authorised, Last updated: 07/04/2020 -
List item
Human medicine European public assessment report (EPAR): Triumeq (updated)
abacavir sulfate, dolutegravir sodium, lamivudine, HIV Infections
Date of authorisation: 31/08/2014,
, Revision: 15, Authorised, Last updated: 07/04/2020
-
List item
Human medicine European public assessment report (EPAR): Armisarte (previously Pemetrexed Actavis) (updated)
pemetrexed diacid monohydrate, Carcinoma, Non-Small-Cell Lung, Mesothelioma
Date of authorisation: 18/01/2016, Revision: 7, Authorised, Last updated: 07/04/2020 -
List item
Human medicine European public assessment report (EPAR): Kivexa (updated)
abacavir, lamivudine, HIV Infections
Date of authorisation: 16/12/2004, Revision: 30, Authorised, Last updated: 07/04/2020 -
List item
Human medicine European public assessment report (EPAR): Budesonide/Formoterol Teva Pharma B.V.
budesonide / formoterol fumarate dihydrate, Asthma, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 03/04/2020, Authorised, Last updated: 07/04/2020 -
List item
News: Global regulators discuss observational studies of real world data for COVID-19 medicines
Last updated: 07/04/2020